“…We have been interested in identifying potential novel anti-TB compounds from natural sources [ 42 , 43 ], cyclic depsipeptides [ 44 ], and synthetic heterocyclic compounds having pharmacophores, such as benzothiazoles, triazolyl 1,2,3,4-tetrahydropyrimidines, dihydropyrimidines, and substituted indolizines as potential antitubercular agents [ 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 ]. In continuation of our efforts in identifying promising heterocyclic compounds for pharmacological activity [ 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 ], this study aims to identify potential anti-TB compounds.…”